Skip to content

DR. NIJS JOCHEN

Active Private limited companyfounded 2009active for 17 yearsEngelbamp 10, 3800 Sint-TruidenKBO/BCE: BE 0809.384.430

Lifetime

17 annual accounts with figures on one time axis
peak of €195,998 in 2011
€126,696▼ 15.1%
lowest -€31,091 in 2018
€78,751▼ 18.3%
peak of €416,379 in 2017
€382,251▲ 6.5%
€62,008▼ 28.7%
Board1 name since 2009
1 director
Documentsfilings and deeds
17-07-202614 days before the deadline
2025abbreviated format
Gross margin from €149,154 to €126,696Dividend €55,440Debts from €86,948 to €62,008

Key points

from the 2025 annual accounts

Equity

€382,251 ▲ 6.5%
358,9402024+78,751Profit-55,440Dividend382,2512025

DR. NIJS JOCHEN paid out €55,440 in dividends. That is 70% of the 2025 profit.

Turnover

≈ €240,000 estimated

The accounts state no turnover.

Filings

17 annual accounts since 2009
AprilJune31 JulyOctober2010201520202025

Two of the last ten came late. The 2017 accounts came in latest, 31 days after the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 34,724 companies had the same profile as DR. NIJS JOCHEN has now. Each dot stands for 87 companies, two years later.

95.3%
were still trading
4.0%
stopped another way
0.7%
went bankrupt
  • Micro
  • 10 to 20 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,894 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 34,724 companies, not a prediction for DR. NIJS JOCHEN. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Manager
  • deed of 11-12-2013

Shares in 1 company,

Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0809384430
changes role from manager to director Discharge granted to · General meeting of 20-02-2020 · Gazette deed
Capital decrease of €93,600 to €18,600 The capital fell from €112,200 to €18,600 · General meeting of 27-12-2017 · Gazette deed
Capital increase of €93,600 to €112,200 After the increase, the capital stands at €112,200 · Contribution by · holds 100 shares · General meeting of 27-11-2013 · Gazette deed
All 33 events

Comparable companies

same main activity, similar in size and age
Company
DR. NIJS JOCHEN Sint-Truiden €444,259 €126,696 86.0% -
Dokter Schrooten Leen Beringen €415,385 €130,330 34.4% -
DR. ELKE VAN HOYWEGHEN Genk €480,604 €136,758 82.3% -
Dr.Daan Walgraeve Hasselt €448,373 €138,421 69.2% -
GIENEES Lokeren €433,465 €127,073 20.0% -
DOCTEUR ARNAUD KERZMANN Raeren €455,876 €123,109 99.3% -
COLUMELLE Mons €407,560 €125,184 30.9% -

These companies have the same main activity as DR. NIJS JOCHEN: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €408,000 and €481,000, founded between 2007 and 2010.

Official details

Source: KBO
Status
Active since 21-01-2009Normal situation
Activity
Specialist medical practiceNACE 86220
Establishment units
2.202.713.3153800 Sint-Truiden, since 21-01-2009
2.202.714.4043800 Sint-Truiden, since 21-01-2009
Financial year end
31 December
Peppol
Reachable since 09-12-2024
Company details

Annual accounts 2025

€444,259▼ 0.4%
Filing
Filed on 17-07-2026, 14 days before the end of the filing period
Financials

Insights on DR. NIJS JOCHEN

DR. NIJS JOCHEN files the abbreviated format. That format states no turnover. The gross margin fell from €150,644 in 2009 to €126,696 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about DR. NIJS JOCHEN

What is the company number of DR. NIJS JOCHEN?
The company number of DR. NIJS JOCHEN is 0809.384.430. The VAT number is the same number with BE in front: BE 0809.384.430.
Where is DR. NIJS JOCHEN based?
The registered office is at Engelbamp 10, 3800 Sint-Truiden.Company details
What does DR. NIJS JOCHEN do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of DR. NIJS JOCHEN?
DR. NIJS JOCHEN is a private limited company (BV).
When was DR. NIJS JOCHEN founded?
DR. NIJS JOCHEN was founded on 21-01-2009.
Is DR. NIJS JOCHEN still active?
Yes, DR. NIJS JOCHEN is an active enterprise in the KBO register.
What is the turnover of DR. NIJS JOCHEN?
The turnover in financial year 2025 is about €240,000. This figure is estimated from the gross margin of €126,696 and 40 comparable companies (NACE 86220). It probably lies between €200,000 and €310,000.Financials
Is DR. NIJS JOCHEN profitable?
In financial year 2025, DR. NIJS JOCHEN made a profit of €78,751.
Where can I find the annual accounts of DR. NIJS JOCHEN?
DR. NIJS JOCHEN filed 17 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of DR. NIJS JOCHEN due?
DR. NIJS JOCHEN must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.